← Leaderboards
Xuyi Yue
Nemours Children'S Hospital, Delaware
$568,000
Attributed
$568,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $213K · FY2021–23$250K$187.5K$125K$62.5K$0
'21
'22
'23
Funding mix
By agency
NIH$568,000 · 1
By mechanism
R21$568,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Covid-19 Mortality”
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Yunda Huang · Fred Hutchinson Cancer Center$20,224,562
- Greg Witham · Anp Technologies, Inc.$19,727,817
- Gaurav J Dave · Duke University$15,697,748
- Mark Brian Reed · San Diego State University$13,504,006
- David N. Wholley · Foundation For The Nih$8,138,253
Research focus
Covid-19 MortalityCovid-19 PatientAffect2019-NcovAdultCovid-19 PandemicAngiotensin IiAngiotensin ReceptorAce2AffinityBindingAngiotensin-Converting Enzyme InhibitorsBiodistributionAngiotensin IBlood Pressure RegulationCardiovascular DiseasesCellsChildAnimal ModelComorbidityCoronavirusCovid-19Covid-19 DetectionCovid-19 Severity
Grant awards (3)
Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2)$177,500
R21 · FY2023 · EB · contact PI
Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2)$177,500
R21 · FY2022 · EB · contact PI
Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2)$213,000
R21 · FY2021 · EB · contact PI